Trial Profile
UFT/LEUCOVORIN AND MITOMYCIN C IN THE TREATMENT OF METASTATIC COLORECTAL CANCER OXALIPLATIN AND IRINOTECAN RESISTANT.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2012
Price :
$35
*
At a glance
- Drugs Mitomycin (Primary) ; Tegafur/uracil (Primary) ; Folinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms MITOUFT
- 27 Jul 2011 New trial record